Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23509322 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2
Condition: Neoplasms, Breast
Interventions: Drug: lapatinib (GW572016) oral tablets;   Drug: paclitaxel infusion

Indicates status has not been verified in more than two years